Form 8-K - Current report:
SEC Accession No. 0001104659-25-063075
Filing Date
2025-06-26
Accepted
2025-06-26 16:45:17
Documents
12
Period of Report
2025-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518727d1_8k.htm   iXBRL 8-K 35505
  Complete submission text file 0001104659-25-063075.txt   202069

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA swtx-20250626.xsd EX-101.SCH 3029
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20250626_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20250626_pre.xml EX-101.PRE 22368
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518727d1_8k_htm.xml XML 3571
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 251080964
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)